Omron and Qualcomm Ventures returned to help AliveCor close a series E round that will fund the bolstering of its advanced ECG system.

The $11.5m Echo Health Ventures-backed round more than doubled the healthcare navigation app developer's overall funding.

MTG Ventures and Ohara Pharmaceutical backed the second close of the medical data modelling technology developer’s latest round, which stands at $12.4m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.

Chronic illness drug developer Sigilon Therapeutics has filed to go public after raising almost $200m from investors including Eli Lilly.

Pfizer Ventures is the largest individual shareholder in the cancer therapeutics developer, which has filed for a $100m offering.

The University of Cambridge-aligned healthcare and life sciences accelerator has added Novartis as a strategic partner.

The biotech investment firm is the first external life sciences investor to get a fund commitment from pharmaceutical company Sanofi.

Existing backers Takeda, Deerfield and Bay City Capital have provided $10m to help progress research from multiple institutions.